Latest Interviews
"New Jersey is home to eight of the top 10 global biopharmaceutical companies, nine of the top 10 R&D firms, and over 5,600 life sciences establishments. The State accounted for 43% of all novel FDA approvals in the past two years."
62222
“Our strategy is straightforward: acquire underperforming assets, inject capital, bring in the right expertise, and turn these assets around, making them more investable.”
62217
“Cada año fortalecemos nuestra visión `multilatina´ para movernos con flexibilidad. Si una oportunidad no cristaliza en un país, podemos encontrarla en otro, así nos mantenemos atentos y ajustamos la estrategia a cada mercado.”
62214
“The growth of infrastructure and allocation of state budgets over the last several administrations have spurred significant growth in newly industrialized areas.”
62215
“Hemos optado por desarrollar nuestro propio software de control de calidad y procesamiento geofísico, ya que preferimos crear nuestras propias soluciones en lugar de depender de un software comercial.”
62212
"In manufacturing, there are only two ways to increase capacity: add a second shift and invest in technology. We have undertaken both of these at B&D Manufacturing."